First Manhattan’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-6,400
| Closed | -$14K | – | 1817 |
|
2022
Q3 | $14K | Hold |
6,400
| – | – | ﹤0.01% | 1156 |
|
2022
Q2 | $19K | Sell |
6,400
-6,000
| -48% | -$17.8K | ﹤0.01% | 1129 |
|
2022
Q1 | $84K | Hold |
12,400
| – | – | ﹤0.01% | 914 |
|
2021
Q4 | $103K | Hold |
12,400
| – | – | ﹤0.01% | 870 |
|
2021
Q3 | $92K | Sell |
12,400
-26,000
| -68% | -$193K | ﹤0.01% | 877 |
|
2021
Q2 | $261K | Hold |
38,400
| – | – | ﹤0.01% | 685 |
|
2021
Q1 | $394K | Hold |
38,400
| – | – | ﹤0.01% | 581 |
|
2020
Q4 | $268K | Sell |
38,400
-5,600
| -13% | -$39.1K | ﹤0.01% | 611 |
|
2020
Q3 | $359K | Hold |
44,000
| – | – | ﹤0.01% | 556 |
|
2020
Q2 | $303K | Hold |
44,000
| – | – | ﹤0.01% | 575 |
|
2020
Q1 | $209K | Hold |
44,000
| – | – | ﹤0.01% | 607 |
|
2019
Q4 | $384K | Hold |
44,000
| – | – | ﹤0.01% | 570 |
|
2019
Q3 | $146K | Sell |
44,000
-30,000
| -41% | -$99.5K | ﹤0.01% | 745 |
|
2019
Q2 | $366K | Hold |
74,000
| – | – | ﹤0.01% | 591 |
|
2019
Q1 | $458K | Hold |
74,000
| – | – | ﹤0.01% | 575 |
|
2018
Q4 | $249K | Hold |
74,000
| – | – | ﹤0.01% | 652 |
|
2018
Q3 | $481K | Hold |
74,000
| – | – | ﹤0.01% | 583 |
|
2018
Q2 | $566K | Sell |
74,000
-4,000
| -5% | -$30.6K | ﹤0.01% | 534 |
|
2018
Q1 | $1.74M | Hold |
78,000
| – | – | 0.01% | 374 |
|
2017
Q4 | $994K | Buy |
78,000
+47,000
| +152% | +$599K | 0.01% | 448 |
|
2017
Q3 | $482K | Buy |
+31,000
| New | +$482K | ﹤0.01% | 545 |
|